
Hyderabad Doctor Secures Rare Disease Drug for Children at ₹2.5 Lakh
What Happened?
Dr. Sivaranjani Santosh has arranged for tiratricol, a drug costing ₹9 crore annually, to be provided free to seven children with Allan-Herndon-Dudley syndrome in India.
Key points
- Tiratricol, a treatment for Allan-Herndon-Dudley syndrome, costs ₹9 crore per year in the US.
- Dr. Santosh collaborated with Access to Medicines India to bring the drug from the Netherlands.
- The cost was reduced to ₹2.5 lakh per child per year through this initiative.
- Seven children diagnosed with the syndrome will receive the medicine free of charge.
- Parents played a crucial role in reaching out to Dr. Santosh for assistance.
- The government is urged to ensure local compounding of the drug under the National Rare Diseases Policy.
Key insights
- The successful import of tiratricol could inspire similar initiatives for other rare diseases.
- Local production of the drug may reduce costs further and improve accessibility.
- Increased awareness among parents can lead to better support networks for affected families.
Why it matters
This initiative could significantly improve the health outcomes for children suffering from a rare genetic condition.
Tags
Entities
Source
Times Now